Morphological Progression of Myelin Abnormalities in IgM-Monoclonal Gammopathy of Undetermined Significance Anti-Myelin-Associated Glycoprotein Neuropathy-Reference-Cited by-同舟云学术

Morphological Progression of Myelin Abnormalities in IgM-Monoclonal Gammopathy of Undetermined Significance Anti-Myelin-Associated Glycoprotein Neuropathy

Published:2010-11 Issue:11 Volume:69 Page:1143-1157
ISSN:0022-3069
Container-title:Journal of Neuropathology & Experimental Neurology
language:en
Short-container-title:J Neuropathol Exp Neurol

Author:

Kawagashira Yuichi,Koike Haruki,Tomita Minoru,Morozumi Saori,Iijima Masahiro,Nakamura Tomohiko,Katsuno Masahisa,Tanaka Fumiaki,Sobue Gen

Publisher

Oxford University Press (OUP)

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Neurology,General Medicine,Pathology and Forensic Medicine

Reference52 articles.

1. Peripheral neuropathies associated with monoclonal proteins: A clinical review

2. Monoclonal gammopathy and neuropathy: Myelin-associated glycoprotein reactivity and clinical characteristics

3. Peripheral neuropathy associated with monoclonal IgM autoantibody

4. Peripheral neuropathy and anti-MAG antibodies;Latov;Crit Rev Neurobiol,1988

5. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinaemia;Smith;A clinical and neurophysiological study. Brain,1994

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibodies in Autoimmune Neuropathies;Neurology;2024-08-27

2. Neurosurgical Intervention for Nerve and Muscle Biopsies;Diagnostics;2024-05-31

3. Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology;Journal of the Peripheral Nervous System;2024-04-10

4. Paraproteinemia‐associated neuropathy with or without anti‐myelin‐associated glycoprotein antibody;Clinical and Experimental Neuroimmunology;2024-02-26

5. Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials;Arquivos de Neuro-Psiquiatria;2024-02-07